Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.65 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.65 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.65 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 3/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | F2 | P00734 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 3/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | GAA | P10253 | 2/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | PPARG | P37231 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28875175 | 1.00 | TDP1 (0.68) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| Ethylene Glycol SCHEMBL15661698 | 0.93 | ALDH1A1 (0.62) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL9817384 | 0.91 | TDP1 (0.59) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL4570317 | 0.91 | TDP1 (0.59) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL21953404 | 0.91 | TDP1 (0.67) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL7935103 | 0.89 | TDP1 (0.57) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL2652364 | 0.89 | LMNA (0.58) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL5157212 | 0.89 | LMNA (0.70) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL5210552 | 0.89 | TDP1 (0.57) | TDP1MAPK1HIF1ASLC6A2SLC6A3 | |
| SCHEMBL7371028 | 0.89 | TDP1 (0.57) | TDP1MAPK1HIF1ASLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 579 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117070156-A | Ultraviolet-resistant aging-resistant PVC adhesive tape and preparation system thereof | 福建友谊胶粘带集团有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-116003447-A | Hg used in aqueous solution 2+ Fluorescent probe for ion detection | 沈阳化工大学 | 2023-04-25 | — | — | CN | claimed |
| CN-110573535-B | Electron donors for ziegler-natta precatalyst preparation and catalyst systems for olefin polymerization | 格雷斯公司 | 2022-07-08 | — | — | CN | claimed |
| CN-107207700-B | Method for synthesizing polyoxazolidone compound with high stability | 科思创德国股份有限公司 | 2021-04-27 | — | — | CN | claimed |
| CN-110573535-A | Electron donors for ziegler-natta precatalyst preparation and catalyst systems for olefin polymerization | 格雷斯公司 | 2019-12-13 | — | — | CN | claimed |
| US-10385167-B2 | Process for the synthesis of polyoxazolidinone compounds with high stability | COVESTRO DEUTSCHLAND AG (DE) | 2019-08-20 | — | — | US | claimed |
| EP-3256508-B1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2019-03-27 | — | — | EP | claimed |
| US-20180022871-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2018-01-25 | — | — | US | claimed |
| EP-3256508-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | Covestro Deutschland AG (DE) | 2017-12-20 | — | — | EP | claimed |
| WO-2016128380-A1 | PROCESS FOR THE SYNTHESIS OF POLYOXAZOLIDINONE COMPOUNDS WITH HIGH STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-08-18 | — | — | WO | claimed |
| EP-0489536-A2 | Olefin polymerisation catalysts | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-06-10 | — | — | EP | claimed |
| EP-0263492-B1 | RETINOIDS, THEIR PREPARATION AND USE AS PHARMACEUTICAL COMPOUNDS | F. HOFFMANN-LA ROCHE AG (CH) | 1991-03-13 | — | — | EP | claimed |
| US-4900478-A | SKIN DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1990-02-13 | — | — | US | claimed |
| US-12623478-B2 | Thermosensitive recording layer forming liquid, thermosensitive recording medium and production method thereof, and image recording method | RICOH COMPANY, LTD. (JP) | 2026-05-12 | — | — | US | disclosed |
| WO-2026087975-A1 | THERMOSENSITIVE RECORDING MEDIUM AND IMAGE RECORDING METHOD | RICOH COMPANY, LTD. (JP) | 2026-04-30 | — | — | WO | disclosed |
| EP-4733080-A1 | HEAT-SENSITIVE RECORDING BODY AND METHOD FOR PRODUCING SAME | Nippon Paper Industries Co., Ltd. (JP) | 2026-04-29 | — | — | EP | disclosed |
| US-4313956-A | Novel sypathomimetic amine prodrugs | INTERX RESEARCH CORP. (US) | 1982-02-02 | — | — | US | disclosed |
| US-4311706-A | ADRENERGIC STIMULANTS | INTERX RESEARCH CORPORATION (US) | 1982-01-19 | — | — | US | disclosed |
| US-4026798-A | PROLONGING USE | FMC CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4013575-A | Dry cleaning with peracids | FMC CORPORATION (US) | 1977-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12623478-B2 | Thermosensitive recording layer forming liquid, thermosensitive recording medium and production method thereof, and image recording method | TRPA1, ASIC1, LRBA | TDP1 2624/4885MAPK1 308/4885HIF1A 1935/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.